Ongar, United Kingdom

Steven James Stanway

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Spero Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven James Stanway. Retrieved from https://idiyas.com/inventor/steven-james-stanway-3wi2m31s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Steven James Stanway

Introduction

Steven James Stanway is an accomplished inventor based in Ongar, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating bacterial infections. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Stanway holds a patent for "Polymyxin compounds and uses thereof." This invention provides a compound of formula (I) and its application in methods of treatment, including the treatment of bacterial infections. The patent outlines methods for preparing the compound and specifies the structural components that differentiate it from other amino acid residues. This innovative approach has the potential to enhance treatment options for bacterial infections.

Career Highlights

Stanway is currently associated with Spero Therapeutics, Inc., where he continues to work on groundbreaking research in the pharmaceutical industry. His role at the company allows him to collaborate with other experts in the field and contribute to the development of new therapeutic solutions.

Collaborations

Throughout his career, Stanway has worked alongside talented professionals such as Pamela Brown and Michael Dawson. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Steven James Stanway's contributions to the field of pharmaceuticals, particularly through his patent on Polymyxin compounds, highlight his role as a significant inventor. His work continues to impact the treatment of bacterial infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…